Published in Sleep on June 01, 1997
The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG | NCT03227393
Autonomic nerve activity and atrial fibrillation. Heart Rhythm (2006) 1.33
Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.21
Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol (2011) 1.10
Arrhythmias and vagus nerve stimulation. Heart Fail Rev (2011) 1.07
Neural mechanisms of atrial fibrillation. Curr Opin Cardiol (2012) 1.04
New concepts in atrial fibrillation: mechanism and remodeling. Med Clin North Am (2008) 0.85
Local innervation and atrial fibrillation. Circulation (2013) 0.82
New concepts in atrial fibrillation: neural mechanisms and calcium dynamics. Cardiol Clin (2009) 0.82
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
Effectiveness of a new decisional algorithm in managing mandibular ameloblastomas: a 10-years experience. Br J Oral Maxillofac Surg (2006) 1.76
p63 expression in odontogenic cysts. Int J Oral Maxillofac Surg (2005) 1.73
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J (2004) 1.66
Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol (1992) 1.66
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J (2002) 1.59
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace (1999) 1.41
[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. G Ital Cardiol (1996) 1.39
Quality management in the prophylaxis of venous thrombembolism--results of a survey including 464 medical and surgical patients. Vasa (2011) 1.39
Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood (1991) 1.23
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation (2001) 1.18
A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure. Am Heart J (1999) 1.17
Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet (2003) 1.13
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol (1994) 1.09
Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J (2001) 1.09
[Guidelines for the use of the implantable defibrillator. Combined task force of the Italian Group of Arrhythmia and the Italian Association of Cardiostimulation]. G Ital Cardiol (1992) 1.06
Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure. Am J Cardiol (1998) 1.01
Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol (2011) 1.01
Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99
Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol (1994) 0.99
Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol (1992) 0.97
Multiple 3D inversion recovery imaging for volume T1 mapping of the heart. Magn Reson Med (2012) 0.95
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med (1997) 0.94
Oral Syphilis: a retrospective analysis of 12 cases and a review of the literature. Oral Dis (2013) 0.93
Electrophysiological basis for arrhythmias caused by acute ischemia. Role of the subendocardium. J Mol Cell Cardiol (1986) 0.92
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91
Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J Interv Card Electrophysiol (2001) 0.91
[Paroxysmal atrial fibrillation: study of the pattern of onset using dynamic electrocardiography]. Cardiologia (1989) 0.89
Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification. Minerva Cardioangiol (2007) 0.85
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Int J Immunopathol Pharmacol (2011) 0.85
Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing. Pacing Clin Electrophysiol (1992) 0.84
Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol (1998) 0.84
Involvement of the oral cavity in psoriasis: results of a clinical study. Br J Dermatol (2014) 0.84
Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. Chest (1995) 0.83
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (2002) 0.83
Skeletal muscle training in chronic heart failure. Acta Physiol Scand (2001) 0.83
Oral squamous cell carcinoma and biological markers: an update on the molecules mainly involved in oral carcinogenesis. Minerva Stomatol (2007) 0.83
P-wave dispersion index: a marker of patients with paroxysmal atrial fibrillation. Int J Cardiol (1996) 0.83
Genetic analysis of oral squamous cell carcinoma by cDNA microarrays focused apoptotic pathway. Int J Immunopathol Pharmacol (2006) 0.83
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. Pacing Clin Electrophysiol (2000) 0.83
Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections. Histopathology (1995) 0.82
MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts. Oral Dis (2010) 0.82
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82
Multidisciplinary and multisetting team management programme in heart failure patients affects hospitalisation and costing. Int J Cardiol (2005) 0.82
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol (1999) 0.82
Variability of recovery of excitability in the normal canine and the ischaemic porcine heart. Eur Heart J (1985) 0.81
Drugs, surgery, cardioverter defibrillator: a decision based on the clinical problem. Pacing Clin Electrophysiol (1993) 0.80
p63 expression correlates with pathological features and biological behaviour of odontogenic tumours. Histopathology (2006) 0.80
The calcium paradox: an electrophysiological study in the isolated rabbit heart. Eur Heart J (1983) 0.80
Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses. Eur J Clin Pharmacol (1986) 0.80
Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beats. Clin Cardiol (1989) 0.79
Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia. Haematologica (2001) 0.79
Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design. Am J Cardiol (1999) 0.78
Usefulness of nicorandil in congestive heart failure. Am J Cardiol (1990) 0.78
p53 and BCL-2 over-expression inversely correlates with histological differentiation in occupational ethmoidal intestinal-type sinonasal adenocarcinoma. Int J Immunopathol Pharmacol (2011) 0.78
Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach. Eur Ann Allergy Clin Immunol (2012) 0.78
Flecainide: evidence of non-linear kinetics. Eur J Clin Pharmacol (1991) 0.78
Indications for implantable cardioverter defibrillator (ICD) therapy. Europace (2001) 0.78
Electrophysiologic properties of prenalterol. Int J Cardiol (1983) 0.78
[Cerebral and renal aspergillosis in a patient with orthotopic heart transplant: diagnosis, treatment and follow-up]. Cardiologia (1989) 0.77
Exercise training in heart failure: effect on morbidity and mortality. Int J Cardiol (2000) 0.77
Adhesion and growth of osteoblast-like cells on laser-engineered porous titanium surface: expression and localization of N-cadherin and beta-catenin. J Biol Regul Homeost Agents (2013) 0.77
Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. Vet J (2000) 0.77
Multicenter clinical evaluation of a new SSIR pacemaker. Pacing Clin Electrophysiol (1992) 0.77
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. Oral Dis (2015) 0.76
Toxic, DNA-damaging and mutagenic activity of epichlorohydrin on human cells cultured in vitro. Tumori (1983) 0.76
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. Am Heart J (2000) 0.76
Safety of a controlled-release flecainide acetate formulation in the prevention of paroxysmal atrial fibrillation in outpatients. Ann Cardiol Angeiol (Paris) (2003) 0.76
Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J (1996) 0.76
SPARTACUS: underdiagnosis of chronic daily headache in primary care. Neurol Sci (2012) 0.76
p63 expression in laryngeal squamous cell carcinoma is related to tumor extension, histologic grade, lymph node involvement and clinical stage. J Biol Regul Homeost Agents (2013) 0.76
Winning the war, far, in developing countries. Novel anticoagulants as a new weapon against stroke. Int J Cardiol (2011) 0.76
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. Int J Clin Pract (2011) 0.75
Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol (1998) 0.75
Intravenous administration of propafenone. J Am Coll Cardiol (1992) 0.75
Hospitalization in ICD recipients. Eur Heart J (2000) 0.75
Studies on conversion of recent onset AF to sinus rhythm have to be controlled. Eur Heart J (1995) 0.75
Prolonged QRS and QTc interval and mortality. Heart (2008) 0.75
Trail overexpression inversely correlates with histological differentiation in intestinal-type sinonasal adenocarcinoma. Int J Surg Oncol (2013) 0.75
Short-, mid-, and long-term effects of a polymer-free tacrolimus-eluting stent in a porcine coronary model. J Biomed Mater Res A (2009) 0.75
Oral health conditions of the elderly in Ancona: a population-based study. Minerva Stomatol (2015) 0.75
Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial. Minerva Cardioangiol (2007) 0.75
A case of sinus arrest and vagal overactivity during REM sleep. Clin Auton Res (1999) 0.75
Effect of antioxidants on mutagenesis induced by DMBA in human cells. Nutr Cancer (1986) 0.75
Peri-tumoral inflammatory cell infiltration in OSCC: a reliable marker of local recurrence and prognosis? An investigation using artificial neural networks. Int J Immunopathol Pharmacol (2011) 0.75